KPV

What Is KPV?

KPV takes its name directly from its structure: lysine, proline, and valine, the three amino acids that make it up. It corresponds to the very end of alpha-MSH, a hormone the body produces that's best known for its role in skin pigmentation but that also plays a broader role in regulating inflammation throughout the body.

What makes KPV interesting to researchers is that this small fragment retains some of alpha-MSH's anti-inflammatory activity without needing to activate the classical melanocortin receptors that drive pigmentation. That distinction has made it a subject of research specifically in conditions where inflammation is the target, separate from any tanning-related effects.

What KPV Is Being Researched For

• Gut Inflammation

  A significant body of KPV research has focused on inflammatory bowel conditions, where studies have found it reduces markers of inflammation in animal models of colitis.^[1]

• Skin Inflammation

  KPV has also been studied in models of skin inflammation, building on its parent hormone's known anti-inflammatory role in that tissue.

• Inflammatory Signaling Pathways

  Beyond specific tissues, foundational research has focused on exactly how KPV produces its anti-inflammatory effect at the cellular level, including comparisons to how the full-length alpha-MSH hormone works.^[2]

How KPV Works

• Blocking Inflammatory Signaling

  Research points to KPV inhibiting NF-kB, a signaling pathway that plays a central role in triggering inflammation across many cell types. By interfering with this pathway, KPV has been shown to reduce the production of inflammatory signaling molecules.^[1][2]

• A Different Route Than Its Parent Hormone

  Research points to KPV producing its anti-inflammatory effect without significantly activating the classical melanocortin receptors that alpha-MSH uses. Studies have found KPV's effects persist even when those receptors are blocked, suggesting it works through a separate mechanism than the hormone it's derived from.^[2]

• Getting Into Cells

  Research on KPV in the gut has pointed to a specific transporter protein called PepT1 as the route by which KPV enters intestinal cells, a detail that helped explain how such a small peptide could reach its target from inside the gut.^[1]

Reconstitution and Handling

KPV is typically supplied as a lyophilized powder in a sealed vial and reconstituted with bacteriostatic water before use in a research setting. Water should be added slowly rather than injected directly into the powder, and the vial should be swirled, not shaken.

Since the amount of water used affects the concentration of the final solution, researchers often use a dosage calculator to work this out before mixing. Once reconstituted, the solution is kept refrigerated to help preserve its stability.

Key Takeaways

KPV stands out among alpha-MSH-derived peptides for retaining anti-inflammatory activity while apparently sidestepping the pigmentation pathway associated with the full hormone. Its research base centers on NF-kB inhibition, with a particular focus on gut inflammation and a well-characterized transport mechanism that explains how it reaches its target tissue. It remains a research compound without published human trial data.

Frequently Asked Questions

Sources and Research

1. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178.
2. Getting SJ, Schiöth HB, Perretti M. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. J Pharmacol Exp Ther. 2003;306(2):631-637.